Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
US8349353B2 · kind B2 · utility
17Cited by
9References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2009 |
| Grant date | Jan 8, 2013 |
| Priority date | — |
| Expiry date | Feb 16, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0046
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with cytotoxic agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.